Depravan ER 75 Tablet Tablet PR
Marketer
Matias Healthcare Pvt Ltd
Salt Composition
Venlafaxine (75mg)
Overview Depravan ER 75 Tablet Tablet PR
SerenEase XR 75mg tablets are indicated for managing depression and anxiety. This medication modifies brain chemistry, alleviating anxiety symptoms like agitation, restlessness, poor concentration, tiredness, perspiration, rapid heartbeat, and racing thoughts. Take SerenEase XR 75mg with food, consistently at the same time daily for optimal blood levels. If a dose is missed, take it immediately upon remembering; do not skip doses and complete the prescribed course, even if feeling improved. Abrupt cessation may exacerbate symptoms. Common side effects include nausea, vomiting, sleep disturbances, reduced appetite, anxiety, constipation, increased sweating, and sexual difficulties. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until effects are known. Most side effects are transient and self-limiting. Consult your physician if side effects persist or are bothersome. Prior to commencing SerenEase XR 75mg, disclose any kidney, heart, or liver conditions, or history of seizures to your doctor. Report any unusual mood or behavioral shifts, worsening depression, or suicidal ideation immediately.
Primary Ingredients of Depravan ER 75 Tablet Tablet PR
The provided text is "undefined," therefore no rewriting is possible.
Uses of Depravan ER 75 Tablet Tablet PR
Mood disorders encompassing depressive and anxious symptoms
Major Benefits of Depravan ER 75 Tablet Tablet PR:
Follow your physician's instructions or consult the product labeling for administration guidance. Ingest Depravan ER 75mg tablets with a meal.
Common Side effects of Depravan ER 75 Tablet Tablet PR:
- Nausea
- Vomiting
- Dizziness
- Insomnia (difficulty in sleeping)
- Decreased appetite
- Anxiety
- Constipation
- Increased sweating
- Sexual dysfunction
How to use Depravan ER 75 Tablet Tablet PR:
Follow your physician's instructions or consult the product label for proper administration. Ingest Depravan ER 75mg tablets with a meal.
How Depravan ER 75 Tablet Tablet PR works:
Depravan ER 75 extended-release tablets elevate brain levels of serotonin and noradrenaline, neurotransmitters crucial for emotional equilibrium.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol use with Depravan ER 75mg tablets is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Depravan ER 75mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the potential advantages against any risks prior to prescribing. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Depravan 75 mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk with consequent risk to the infant. Infants should be observed for drowsiness and monitored for appropriate weight increase.
DrivingUNSAFE
Driving ability may be impaired by Depravan ER 75 Tablet PR, due to potential side effects. These side effects include dizziness, confusion, and visual disturbances like blurred vision, all of which can negatively impact driving performance.
KidneyCAUTION
Extended-release Depravan 75 mg tablets require careful administration in individuals with impaired renal function. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with hepatic impairment should exercise caution when using Depravan ER 75mg extended-release tablets. Dosage modification may be necessary; physician consultation is advised.
What if you forget to take Depravan ER 75 Tablet Tablet PR :
Should you forget a dose of Depravan ER 75mg extended-release tablets, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid doubling the prescribed dosage.
Facts to Know About Depravan ER 75 Tablet Tablet PR
| Label | Value |
|---|---|
| Chemical Type | Anisole-based compound |
| Developing Habits | No. |
| Treatment Category | Neuroscience of the Central Nervous System |
| Behavior Class | SNRIs (serotonin-norepinephrine reuptake inhibitors) |


